A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).

Saved in:
Bibliographic Details
Title: A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).
Authors: Poudel S; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Pangeni R; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Huo Z; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA., Farkas D; Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA 23220, USA., Gulec S; Materials Characterization, Anton Paar Inc., Richmond, VA 23298, USA., Zhang Q; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Lasaosa M; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Tong R; Department of Chemical engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA., Moeller FG; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA., Li Q; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Wang Y; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Qin B; Office of Research and Standards, Office of Generic Drugs, CDER, U.S. Food and Drug Administration, Silver Springs, MD 20993, USA., Halquist MS; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA., Xu Q; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, USA; Department of Ophthalmology, Department of Biomedical Engineering, Department of Pediatrics, Center for Pharmaceutical Engineering, Center for Drug Discovery, and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA. Electronic address: qxu@vcu.edu.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 May 10; Vol. 393, pp. 114793. Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-4995
DOI:10.1016/j.jconrel.2026.114793